MYOPORE SUTURELESS MYOCARDIAL PACING LEAD

Permanent Pacemaker Electrode

FDA Premarket Approval P130012

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the myopore sutureless myocardial pacing lead. This device is indicated for when ventricular epicardial attachment is required, or when a transvenous lead cannot provide effective pacing. This type of lead is useful in situations where it is required that the potential for lead dislodgement be diminished or pacing and/or sensing will be established subsequent to open heart surgery.

DeviceMYOPORE SUTURELESS MYOCARDIAL PACING LEAD
Classification NamePermanent Pacemaker Electrode
Generic NamePermanent Pacemaker Electrode
ApplicantGreatbatch Medical
Date Received2013-05-13
Decision Date2015-04-30
Notice Date2015-05-08
PMAP130012
SupplementS
Product CodeDTB
Docket Number15M-1557
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address Greatbatch Medical 2300 Berkshire Lane North minneapolis, MN 55441
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P130012Original Filing
S010 2022-08-08 135 Review Track For 30-day Notice
S009 2022-08-05 30-day Notice
S008 2019-06-19 30-day Notice
S007
S006 2019-01-30 Special (immediate Track)
S005 2018-08-27 30-day Notice
S004
S003 2017-05-12 Special (immediate Track)
S002 2016-08-29 30-day Notice
S001 2016-08-23 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.